Urasaki Y - Search Results

1

Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.

Ueda T, Miyawaki S, Asou N, Kuraishi Y, Hiraoka A, Kuriyama K, Minami S, Ohshima T, Ino T, Tamura J, Kanamaru A, Nishikawa K, Tanimoto M, Oh H, Saito K, Nagata K, Naoe T, Yamada O, Urasaki Y, Sakura T, Ohno R. Ueda T, et al. Among authors: urasaki y. Int J Hematol. 1998 Oct;68(3):279-89. doi: 10.1016/s0925-5710(98)00075-9. Int J Hematol. 1998. PMID: 9846012 Clinical Trial.

2

Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance.

Seo T, Urasaki Y, Ueda T. Seo T, et al. Among authors: urasaki y. Int J Hematol. 2007 Jan;85(1):26-31. doi: 10.1532/IJH97.05142. Int J Hematol. 2007. PMID: 17261498

3

[Treatment of acute lymphoblastic leukemia in adults: a review of 10 year study of Japan Adult Leukemia Study Group].

Fukushima T, Urasaki Y, Ueda T, Tanimoto M. Fukushima T, et al. Among authors: urasaki y. Rinsho Ketsueki. 1997 May;38(5):385-8. Rinsho Ketsueki. 1997. PMID: 9194380 Clinical Trial. Japanese. No abstract available.

4

Successful treatment of cytomegalovirus retinitis in a patient with malignant lymphoma: a case report and review of the literature.

Kawai Y, Kawai R, Nakayama T, Tanizawa A, Urasaki Y, Fukushima T, Yoshida A, Yamauchi T, Tsutani H, Wano Y, Akagi Y, Ueda T. Kawai Y, et al. Among authors: urasaki y. Int J Hematol. 1999 Jun;69(4):256-9. Int J Hematol. 1999. PMID: 10407583 Review.

5

[Chemotherapy of hematological malignancy; principles of treatment].

Ueda T, Urasaki Y. Ueda T, et al. Among authors: urasaki y. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:363-8. Nihon Rinsho. 2007. PMID: 17474433 Review. Japanese. No abstract available.

6

Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.

Urasaki Y, Ueda T, Nakamura T. Urasaki Y, et al. Jpn J Cancer Res. 1994 Jun;85(6):659-64. doi: 10.1111/j.1349-7006.1994.tb02410.x. Jpn J Cancer Res. 1994. PMID: 7914886 Free PMC article.

7

The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.

Tasaki T, Yamauchi T, Matsuda Y, Takai M, Ookura M, Lee S, Tai K, Ikegaya S, Kishi S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Tasaki T, et al. Among authors: urasaki y. Anticancer Res. 2014 Oct;34(10):5631-6. Anticancer Res. 2014. PMID: 25275066

8

Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.

Yamamoto S, Yamauchi T, Kawai Y, Takemura H, Kishi S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Yamamoto S, et al. Among authors: urasaki y. Int J Hematol. 2007 Feb;85(2):108-15. doi: 10.1532/IJH97.06177. Int J Hematol. 2007. PMID: 17321987

9

Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.

Seo T, Urasaki Y, Takemura H, Ueda T. Seo T, et al. Among authors: urasaki y. Anticancer Res. 2005 Mar-Apr;25(2A):991-8. Anticancer Res. 2005. PMID: 15868938 Free article.

10

Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.

Urasaki Y, Ueda T, Yoshida A, Fukushima T, Takeuchi N, Tsuruo T, Nakamura T. Urasaki Y, et al. Anticancer Res. 1996 Mar-Apr;16(2):709-14. Anticancer Res. 1996. PMID: 8687117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters